Misset JL - Search Results

1

When should the immune clock be reset? From circadian pharmacodynamics to temporally optimized drug delivery.

Lévi F, Canon C, Dipalma M, Florentin I, Misset JL. Lévi F, et al. Among authors: misset jl. Ann N Y Acad Sci. 1991;618:312-29. doi: 10.1111/j.1749-6632.1991.tb27251.x. Ann N Y Acad Sci. 1991. PMID: 2006792 Review.

2

A phase I trial of 21-day continuous venous infusion of alpha-interferon at circadian rhythm modulated rate in cancer patients.

Deprés-Brummer P, Levi F, Di Palma M, Beliard A, Lebon P, Marion S, Jasmin C, Misset JL. Deprés-Brummer P, et al. Among authors: misset jl. J Immunother (1991). 1991 Dec;10(6):440-7. doi: 10.1097/00002371-199112000-00008. J Immunother (1991). 1991. PMID: 1768678

3

Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate.

Caussanel JP, Lévi F, Brienza S, Misset JL, Itzhaki M, Adam R, Milano G, Hecquet B, Mathé G. Caussanel JP, et al. Among authors: misset jl. J Natl Cancer Inst. 1990 Jun 20;82(12):1046-50. doi: 10.1093/jnci/82.12.1046. J Natl Cancer Inst. 1990. PMID: 2348469 Clinical Trial.

4

[Biomedical bases of chronobiology].

Lévi F, Misset JL. Lévi F, et al. Among authors: misset jl. Soins. 1992 Nov;(566):10-1. Soins. 1992. PMID: 1290113 French. No abstract available.

5

Chronomodulation of chemotherapy against metastatic colorectal cancer. International Organization for Cancer Chronotherapy.

Lévi F, Giacchetti S, Adam R, Zidani R, Metzger G, Misset JL. Lévi F, et al. Among authors: misset jl. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1264-70. doi: 10.1016/0959-8049(95)00242-b. Eur J Cancer. 1995. PMID: 7577034 Review.

6

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy.

Lévi F, Zidani R, Misset JL. Lévi F, et al. Among authors: misset jl. Lancet. 1997 Sep 6;350(9079):681-6. doi: 10.1016/s0140-6736(97)03358-8. Lancet. 1997. PMID: 9291901 Clinical Trial.

7

Circadian rhythm-modulated (CRM) chemotherapy of metastatic breast cancer with mitoxantrone, 5-fluorouracil, and folinic acid: preliminary results of a phase I trial.

Deprés-Brummer P, Berthault-Cvitkovic F, Lĕvi F, Brienza S, Vannetzel JM, Jasmin C, Misset JL. Deprés-Brummer P, et al. Among authors: misset jl. J Infus Chemother. 1995;5(3 Suppl 1):144-7. J Infus Chemother. 1995. PMID: 8528975 Clinical Trial.

8

Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors.

Touitou Y, Lévi F, Bogdan A, Benavides M, Bailleul F, Misset JL. Touitou Y, et al. Among authors: misset jl. J Cancer Res Clin Oncol. 1995;121(3):181-8. doi: 10.1007/BF01198101. J Cancer Res Clin Oncol. 1995. PMID: 7713990

9

A phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancer.

Lévi F, Soussan A, Adam R, Caussanel JP, Metzger G, Jasmin C, Bismuth H, Smolensky M, Misset JL. Lévi F, et al. Among authors: misset jl. J Infus Chemother. 1995;5(3 Suppl 1):153-8. J Infus Chemother. 1995. PMID: 8528977 Clinical Trial.

10

Chronotherapy with 5-fluorouracil and other drugs in gastrointestinal malignancies. Chronotherapy Group of the European Organization for Research and Treatment of Cancer.

Misset JL, Lévi F. Misset JL, et al. Semin Oncol. 2000 Oct;27(5 Suppl 10):78-82. Semin Oncol. 2000. PMID: 11049036 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters